Effects of peripheral type benzodiazepine antagonist PK 11195 on the lipid-lowering activity of diazepam in albino rats.
B Cuparencu, J Horák
Abstract
B Cuparencu, J Horák
Abstract
The i.p. administration of PK 11195, a peripheral type benzodiazepine receptor antagonist in a dose of 1 mg/kg/day antagonized the action of u.p. injection of diazepam (5 mg/kg/day, 5 days) on serum triglycerides. It seems that the effects of diazepam on serum lipids were due to the stimulation of the peripheral type benzodiazepine receptors.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The i.p. administration of PK 11195, a peripheral type benzodiazepine receptor antagonist in a dose of 1 mg/kg/day antagonized the action of u.p. injection of diazepam (5 mg/kg/day, 5 days) on serum triglycerides. It seems that the effects of diazepam on serum lipids were due to the stimulation of the peripheral type benzodiazepine receptors.
Key concepts: Diazepam, Benzodiazepine, Antagonist, Flumazenil, Pharmacology, GABAA receptor, Stimulation, Receptor